Vaccines are a type of immunotherapy that stimulate the immune system to recognize and fight a specific disease. Cancer vaccines are designed to either prevent or treat cancer. Currently, there are two FDA-approved cancer treatment vaccines–one for melanoma and one for prostate cancer.
Experimental vaccines for metastatic breast cancer are currently being studied in clinical trials. Use the links below to read about how cancer vaccines work, which vaccines are approved for other metastatic cancer, and how to find vaccine and other types of immunotherapy trials for metastatic breast cancer.
What are Cancer Treatment Vaccines?
- Cancer Treatment Vaccines Cancer.gov describes how cancer vaccines work, the types of vaccines, and possible cancer vaccine side effects.
- Tumor Vaccines Dana-Farber Cancer Institute explains the difference between cell-based and protein-based tumor vaccines.
- Cancer Vaccine A research article for people who want more details about the science of cancer vaccine
FDA Approved Treatment Vaccines for Other Metastatic Cancers
- Provenge Provenge is the first FDA-approved vaccine for treating prostate cancer. This video gives a detailed overview of how Provenge works, its safety, efficacy and side effects.
- T-VEC T-VEC (Imlygic®) is the first FDA-approved oncolytic virus therapy for treating melanoma. This article discusses how oncolytic virus therapy works, and current clinical trials studying the oncolytic virus.
Treatment Vaccines for Metastatic Breast Cancer that are Under Investigation
- Vaccine Trials for Advanced Breast Cancer Metastatic Trial Search lists cancer vaccine trials enrolling people with advanced or metastatic breast cancer.
Last Modified on February 23, 2021